In this study, we discovered that CCL2 is significantly overexpressed in ESCC tumor tissues, and its high expression is closely associated with advanced TNM staging and poor survival prognosis, confirming its oncogenic role in ESCC [14, 27]. The gene discussed is CCL2; the disease is neoplasm.